ResearcherChinese University of Hong KongActive in the last 2 years
Chi Han Li
Matched on OpenAlex author ID A5109601946. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 3 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 5
- The molecular mechanism underlying KRAS regulation on STK31 expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/cas.16286↗
- Ectopic HOTTIP expression induces noncanonical transactivation pathways to promote growth and invasiveness in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.canlet.2020.02.038↗
- LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma. First author DOI 10.1016/j.jcmgh.2020.06.009↗
- Histone demethylase JMJD3 disrupts spectrin-dependent cytoskeleton in Pancreatic Ductal Adenocarcinoma cells by regulating H exokinase domain containing 1 expr… Co-author DOI 10.21203/rs.3.rs-30041/v1↗
- Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin. Co-author DOI 10.1053/j.gastro.2013.01.058↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yangchao Chen · 5 shared papers, 2013–2024 · strength 0.59
- Paper The molecular mechanism underlying KRAS regulation on STK31 expression in pancreatic ductal adenocarcinoma. DOI 10.1111/cas.16286↗
- Paper Ectopic HOTTIP expression induces noncanonical transactivation pathways to promote growth and invasiveness in pancreati… DOI 10.1016/j.canlet.2020.02.038↗
- Paper LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2020.06.009↗
- Chi Hin Wong · 3 shared papers, 2020–2024 · strength 0.45
- Paper The molecular mechanism underlying KRAS regulation on STK31 expression in pancreatic ductal adenocarcinoma. DOI 10.1111/cas.16286↗
- Paper Ectopic HOTTIP expression induces noncanonical transactivation pathways to promote growth and invasiveness in pancreati… DOI 10.1016/j.canlet.2020.02.038↗
- Paper LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2020.06.009↗
- Stephen Lam Chan · 3 shared papers, 2013–2024 · strength 0.38
- Paper The molecular mechanism underlying KRAS regulation on STK31 expression in pancreatic ductal adenocarcinoma. DOI 10.1111/cas.16286↗
- Paper Ectopic HOTTIP expression induces noncanonical transactivation pathways to promote growth and invasiveness in pancreati… DOI 10.1016/j.canlet.2020.02.038↗
- Paper Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation… DOI 10.1053/j.gastro.2013.01.058↗
- Yinxin Zhu · 3 shared papers, 2013–2020 · strength 0.24
- Paper LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2020.06.009↗
- Paper Histone demethylase JMJD3 disrupts spectrin-dependent cytoskeleton in Pancreatic Ductal Adenocarcinoma cells by regulat… DOI 10.21203/rs.3.rs-30041/v1↗
- Paper Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation… DOI 10.1053/j.gastro.2013.01.058↗
- Bo Li · 1 shared paper, 2024 · strength 0.23
- Yuting Liu · 1 shared paper, 2024 · strength 0.23
- Zhangang Xiao · 2 shared papers, 2013–2020 · strength 0.14
- Paper Histone demethylase JMJD3 disrupts spectrin-dependent cytoskeleton in Pancreatic Ductal Adenocarcinoma cells by regulat… DOI 10.21203/rs.3.rs-30041/v1↗
- Paper Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation… DOI 10.1053/j.gastro.2013.01.058↗
- Huiyi Feng · 1 shared paper, 2020 · strength 0.11
- Guolin Li · 1 shared paper, 2020 · strength 0.11
- Rufu Chen · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.